Table 3.
Longitudinal estimates of mean per-patient-per-year (PPPY) healthcare costs (US$) using hierarchical generalised linear mixed models
| Adjusted cost ratio (95% CI) | Class 2 | Class 1 | Class 3 | Class 4 |
|---|---|---|---|---|
| Total healthcare costs | Reference | 1.43 (1.26–1.62)*** | 1.17 (1.04–1.30)** | 1.00 (0.89–1.11) |
| OPD care costs | Reference | 1.41 (1.31–1.52)*** | 1.16 (1.09–1.24)*** | 1.07 (1.00–1.14) |
| Acute care costs | Reference | 1.25 (1.11–1.42)*** | 1.06 (0.95–1.18) | 0.96 (0.86–1.07) |
| HDU care costs | Reference | 1.18 (0.83–1.68) | 0.90 (0.64–1.26) | 1.15 (0.83–1.60) |
| ICU care costs | Reference | 1.54 (1.04–2.29)* | 1.37 (0.94–1.99) | 1.55 (1.08–2.23)* |
| Rehabilitation and infirmary care costs | Reference | 1.12 (0.93–1.34) | 1.02 (0.87–1.21) | 0.99 (0.84–1.17) |
| Psychiatric care costs | Reference | 3.30 (1.28–8.47)* | 7.41 (3.37–16.27)*** | 4.72 (1.83–12.23)** |
| A&E care costs | Reference | 1.08 (1.01–1.15)* | 1.06 (0.99–1.12) | 1.00 (0.94–1.06) |
Models were adjusted for alcohol use, family history of diabetes, diastolic BP, plasma albumin, alkaline phosphatase, eGFR, prior severe hypoglycaemia, prior CVD, prior cancer and EQ-5D-3L (mobility, self-care, usual activities, pain/discomfort and anxiety/depression). Psychiatric care cost exhibits high zero-inflation. The model was simplified by including a year-varying random slope only at the individual level, while adjusting for the variables mentioned earlier, except for alcohol use, plasma albumin and alkaline phosphatase
***p<0.001, **p<0.01, *p<0.05
A&E, accident and emergency; CI, confidence interval; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; EQ-5D-3L, EuroQol five-dimensional three-level questionnaire; HDU, high-dependency unit; ICU, intensive care unit; OPD, outpatient department